Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas

Morita,Yoshihiro; Zhang,Roy; Leslie,Macall; Adhikari,Smita; Hasan,Nafis; Chervoneva,Inna; Rui,Hallgeir; Tanaka,Takemi

doi:10.3892/ol.2017.6466

Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas

Authors:
- Yoshihiro Morita
- Roy Zhang
- Macall Leslie
- Smita Adhikari
- Nafis Hasan
- Inna Chervoneva
- Hallgeir Rui
- Takemi Tanaka
View Affiliations

Affiliations: Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA, Department of Pathology, School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA, Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA, Department of Pharmaceutical Sciences, Thomas Jefferson University, Philadelphia, PA 19107, USA, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA, Department of Pathology, Medical College of Wisconsin Cancer Center, Milwaukee, WI 53226, USA
Published online on: June 22, 2017 https://doi.org/10.3892/ol.2017.6466
Pages: 2111-2118
Copyright: © Morita et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor-associated macrophages (TAMs) are major constituents of the tumor microenvironment in solid tumors and have been implicated as mediators of tumor progression, invasion and metastasis. Correspondingly, accumulation of TAMs is associated with unfavorable clinical outcomes in numerous types of solid tumors. E‑selectin is a hallmark of inflammation and a key adhesion molecule that accommodates the initial contact of circulating immune cells with the inflamed vessel surface. Currently, the association between E‑selectin and TAMs is not fully elucidated; therefore, the present study investigated the association between vessel inflammation, TAM infiltration, and clinical outcome in breast cancer. A total of 53 procedure‑naïve invasive breast cancer cases were immunohistochemically analyzed for the presence of cluster of differentiation (CD)68+ TAMs, E‑selectin+ vessels and tumor inflammation. The association between CD68 and E‑selectin expression, and tumor inflammation as well as overall survival was evaluated using Kaplan‑Meier survival curves and multivariable Cox's proportional hazards regression analysis. The abundance of TAMs was identified to be positively associated with tumor inflammation, estrogen receptor and E‑selectin expression levels. A greater prevalence of TAMs and tumor inflammation was significantly associated with shorter overall survival times. E‑selectin expression levels were significantly higher in tumor vessels among elderly patients, but were not associated with overall survival. The abundance of TAMs was associated with the presence of E‑selectin‑expressing inflamed tumor vessels and tumor inflammation, as well as overall survival in patients with invasive breast carcinoma.

View Figures

View References

1	Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
2	Ruffell B and Coussens LM: Macrophages and therapeutic resistance in cancer. Cancer Cell. 27:462–472. 2015. View Article : Google Scholar : PubMed/NCBI
3	Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int Agency Res Cancer. 2014.
4	Newman EA and Newman LA: Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am. 87353–364. (viii)2007. View Article : Google Scholar : PubMed/NCBI
5	Redig AJ and McAllister SS: Breast cancer as a systemic disease: A view of metastasis. J Intern Med. 274:113–126. 2013. View Article : Google Scholar : PubMed/NCBI
6	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
7	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
8	Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI
9	Mueller MM and Fusenig NE: Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 4:839–849. 2004. View Article : Google Scholar : PubMed/NCBI
10	Rakoff-Nahoum S: Why cancer and inflammation? Yale J Biol Med. 79:123–130. 2006.PubMed/NCBI
11	Charpin C, Bergeret D, Garcia S, Andrac L, Martini F, Horschowski N, Choux R and Lavaut MN: ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays. Int J Oncol. 12:1041–1048. 1998.PubMed/NCBI
12	Nguyen M, Corless CL, Kräling BM, Tran C, Atha T, Bischoff J and Barsky SH: Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: A role for tumor-cell-secreted interleukin-1 alpha. Am J Pathol. 150:1307–1314. 1997.PubMed/NCBI
13	Müller AM, Weichert A and Müller KM: E-cadherin, E-selectin and vascular cell adhesion molecule: Immunohistochemical markers for differentiation between mesothelioma and metastatic pulmonary adenocarcinoma? Virchows Arch. 441:41–46. 2002. View Article : Google Scholar : PubMed/NCBI
14	Staal-van den Brekel AJ, Thunnissen FB, Buurman WA and Wouters EF: Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma. Virchows Arch. 428:21–27. 1996. View Article : Google Scholar : PubMed/NCBI
15	Bhaskar V, Law DA, Ibsen E, Breinberg D, Cass KM, DuBridge RB, Evangelista F, Henshall SM, Hevezi P, Miller JC, et al: E-selectin up-regulation allows for targeted drug delivery in prostate cancer. Cancer Res. 63:6387–6394. 2003.PubMed/NCBI
16	Eichbaum MH, de Rossi TM, Kaul S and Bastert G: Serum levels of soluble E-selectin are associated with the clinical course of metastatic disease in patients with liver metastases from breast cancer. Oncol Res. 14:603–610. 2004.PubMed/NCBI
17	Leek RD, Landers RJ, Harris AL and Lewis CE: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer. 79:991–995. 1999. View Article : Google Scholar : PubMed/NCBI
18	Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM and Byers SW: E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer. 60:426–431. 1995. View Article : Google Scholar : PubMed/NCBI
19	Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H and Era S: Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density. Oncol Rep. 14:425–431. 2005.PubMed/NCBI
20	Leek RD and Harris AL: Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia. 7:177–189. 2002. View Article : Google Scholar : PubMed/NCBI
21	Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC and Harris AL: Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res. 62:1326–1329. 2002.PubMed/NCBI
22	Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
23	Joyce JA and Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer. 9:239–252. 2009. View Article : Google Scholar : PubMed/NCBI
24	Berg EL, Robinson MK, Mansson O, Butcher EC and Magnani JL: A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem. 266:14869–14872. 1991.PubMed/NCBI
25	Ley K, Laudanna C, Cybulsky MI and Nourshargh S: Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol. 7:678–689. 2007. View Article : Google Scholar : PubMed/NCBI
26	Luster AD, Alon R and von Andrian UH: Immune cell migration in inflammation: Present and future therapeutic targets. Nat Immunol. 6:1182–1190. 2005. View Article : Google Scholar : PubMed/NCBI
27	Welply JK, Keene JL, Schmuke JJ and Howard SC: Selectins as potential targets of therapeutic intervention in inflammatory diseases. Biochim Biophys Acta. 1197:215–226. 1994. View Article : Google Scholar : PubMed/NCBI
28	Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol. 4:219–229. 1993.PubMed/NCBI
29	Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S and Paulson JC: ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 250:1130–1132. 1990. View Article : Google Scholar : PubMed/NCBI
30	Picker LJ, Kishimoto TK, Smith CW, Warnock RA and Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T cells. Nature. 349:796–799. 1991. View Article : Google Scholar : PubMed/NCBI
31	Shimizu Y, Shaw S, Graber N, Gopal TV, Horgan KJ, Van Seventer GA and Newman W: Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature. 349:799–802. 1991. View Article : Google Scholar : PubMed/NCBI
32	Thomas W: Catch bonds in adhesion. Annu Rev Biomed Eng. 10:39–57. 2008. View Article : Google Scholar : PubMed/NCBI
33	Hidalgo A, Peired AJ, Wild MK, Vestweber D and Frenette PS: Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity. 26:477–489. 2007. View Article : Google Scholar : PubMed/NCBI
34	Matsuura N, Narita T, Hiraiwa N, Hiraiwa M, Murai H, Iwase T, Funahashi H, Imai T, Takagi H and Kannagi R: Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol. 12:1157–1164. 1998.PubMed/NCBI
35	Lester SCI, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, et al: Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 133:1515–1538. 2009.PubMed/NCBI
36	Martinez FO and Gordon S: The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep. 6:132014. View Article : Google Scholar : PubMed/NCBI
37	Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW and Wei YQ: Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. PLoS One. 7:e509462012. View Article : Google Scholar : PubMed/NCBI
38	Wei J, Cui L, Liu F, Fan Y, Lang R, Gu F, Guo X, Tang P and Fu L: E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Int J Surg Pathol. 18:193–200. 2010. View Article : Google Scholar : PubMed/NCBI
39	Mei J, Xiao Z, Guo C, Pu Q, Ma L, Liu C, Lin F, Liao H, You Z and Liu L: Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget. 7:34217–34228. 2016.PubMed/NCBI
40	Lawrence T and Natoli G: Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol. 11:750–761. 2011. View Article : Google Scholar : PubMed/NCBI
41	DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI
42	Pigott R, Dillon LP, Hemingway IH and Gearing AJ: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 187:584–589. 1992. View Article : Google Scholar : PubMed/NCBI
43	Cowley HC, Heney D, Gearing AJ, Hemingway I and Webster NR: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med. 22:651–657. 1994. View Article : Google Scholar : PubMed/NCBI
44	Fassbender K, Mössner R, Motsch L, Kischka U, Grau A and Hennerici M: Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke. 26:1361–1364. 1995. View Article : Google Scholar : PubMed/NCBI
45	Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ and Cashman SJ: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann N Y Acad Sci. 667:324–331. 1992. View Article : Google Scholar : PubMed/NCBI
46	Gearing AJ and Newman W: Circulating adhesion molecules in disease. Immunol Today. 14:506–512. 1993. View Article : Google Scholar : PubMed/NCBI
47	Koch AE, Turkiewicz W, Harlow LA and Pope RM: Soluble E-selectin in arthritis. Clin Immunol Immunopathol. 69:29–35. 1993. View Article : Google Scholar : PubMed/NCBI
48	Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ and Buurman WA: E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology. 77:543–549. 1992.PubMed/NCBI
49	Hebbar M, Révillion F, Louchez MM, Vilain MO, Fournier C, Bonneterre J and Peyrat JP: The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. Clin Cancer Res. 4:373–380. 1998.PubMed/NCBI
50	Ferroni P, Roselli M, Spila A, D'Alessandro R, Portarena I, Mariotti S, Palmirotta R, Buonomo O, Petrella G and Guadagni F: Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients. Cancer. 116:2913–2921. 2010. View Article : Google Scholar : PubMed/NCBI
51	Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q and Szallasi Z: An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
52	Çakar M, Balta Ş, Şarlak H, Akhan M, Demirkol S, Karaman M, Ay SA, Kurt Ö, Çayci T, İnal S and Demirbaş Ş: Arterial stiffness and endothelial inflammation in prediabetes and newly diagnosed diabetes patients. Arch Endocrinol Metab. 59:407–413. 2015. View Article : Google Scholar : PubMed/NCBI
53	Klimiuk PA, Fiedorczyk M, Sierakowski S and Chwiecko J: Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand J Rheumatol. 36:345–350. 2007. View Article : Google Scholar : PubMed/NCBI
54	Kvasnicka T, Kvasnicka J, Ceská R, Grauova B and Vrablík M: Increasing plasma levels of soluble cell adhesion molecules (sE-Selectin, sP-Selectin and sICAM-1) in overweight adults with combined hyperlipidemia. Sb Lek. 102:473–477. 2001.PubMed/NCBI
55	Sacanella E, Estruch R, Badía E, Fernández-Sola J, Nicolás JM and Urbano-Márquez A: Chronic alcohol consumption increases serum levels of circulating endothelial cell/leucocyte adhesion molecules E-selectin and ICAM-1. Alcohol Alcohol. 34:678–684. 1999. View Article : Google Scholar : PubMed/NCBI